Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2017
View Archived Issues
Pfizer begins first-in-human study of PF-06730512
Read More
Bird Rock Bio completes phase I study of namacizumab
Read More
Synereca Pharmaceuticals develops colistin potentiators for resistant Gram-negative infections
Read More
AbCellera Biologics enters influenza vaccine research collaboration with Sanofi Pasteur
Read More
Marina Biotech acquires Prestalia from Symplmed Pharmaceuticals
Read More
FDA approves 2-month dosing option of Alkermes' Aristada
Read More
AstraZeneca agrees to divest ex-Japanese Zomig rights to Grunenthal
Read More
NanoViricides reports promising findings for topical drug candidates for shingles
Read More
First patients in phase II study respond to encochleated amphotericin B
Read More
FDA grants fast track status to Pfizer's Vyndaqel for TTR-CM
Read More
Abiraterone acetate improves survival in men starting hormone therapy for prostate cancer
Read More
Midatech licenses Novartis' panobinostat for evaluation in brain cancers
Read More
Viking Therapeutics reports promising in vivo data on VK-2809 in NASH
Read More
Living Cell Technologies gives update on phase I/IIa study of NTCELL in Parkinson's disease
Read More
Phase II data reported for tazemetostat in synovial sarcoma
Read More
Poxel reports additional results from the phase IIb imeglimin study
Read More
Warner Babcock Institute for Green Chemistry identifies new beta-amyloid aggregation inhibitors
Read More
Oppilan Pharma patents sphingosine 1-phosphate receptor 1 agonists
Read More
Daratumumab shows promise for newly diagnosed multiple myeloma patients
Read More
RQx Pharmaceuticals, Genentech describe novel signal peptidase IB inhibitors
Read More
Araxes Pharma synthesizes new KRAS inhibitors
Read More
CIMA describes novel DNMT/EHMT2 inhibitors
Read More
Novo Nordisk receives European approval for Refixia
Read More
R-Pharm CJSC discloses new tyrosine-protein kinase JAK inhibitors
Read More
Hemophilia A gene therapy from Sangamo and Pfizer receives E.U. orphan drug designation
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe